Boys with Duchenne muscular dystrophy begin receiving 'game-changer' drug |STV News Report 30/05/25

You may have seen a previous story I worked on about Duchenne Muscular Dystrophy. The genetic condition is rare, it predominantly affects young boys and will lead to reduced mobility and on average results in a life expectancy of less than 30 years old. Families have been fighting for a medication called Givinostat to be made available to patients - it can help slow progression of Duchenne. In the last few weeks the first boys across Scotland have begun to receive it. We spoke with Riley and Sam.